We are Main Street
U.S.

HealthTech Bio Actives Acquired Ingredient Firm Specnova

The deal gives the manufacturer new ingredient delivery technologies to support its entry into the U.S. market.

Updated on Oct. 6, 2026 in Healthcare

Bold flat-color editorial illustration showing four concentric circular spheres, representing advanced nutrient delivery technology.
HealthTech Bio Actives has acquired Specnova, a firm specializing in ingredient delivery technology, to bolster its expansion into the U.S. supplement market. AI Illustration. Upload story photo >

Live Poll

Do you believe corporate acquisitions generally lead to better product choices for your household?

HealthTech Bio Actives has completed the acquisition of Specnova, a company known for ingredient delivery platforms. The two companies will continue to operate as independent entities while collaborating on product solutions.

Why it matters

This move allows HealthTech Bio Actives to leverage specialized delivery technologies to differentiate its product formats as it establishes a footprint in the U.S. supplement market.

Founded in 2017, Specnova brings specialized delivery technologies to the partnership, including its LipoVantage liposome and NovaQSpheres beadlet platforms. Financial terms of the acquisition remain undisclosed.

The players

HealthTech Bio Actives

An ingredient manufacturer specializing in vitamin B12 and citrus flavonoids.

Specnova

A developer of specialized ingredient delivery technologies founded in 2017.

The details

Specnova focuses on delivery formats that control how ingredients are released in the body, such as the four-layer creatine beadlets used in BodyTech Elite products. HealthTech Bio Actives, which produces citrus flavonoids and vitamin B12, aims to use these delivery systems to improve performance and create unique consumer product formats.

Timeline

  1. 2017: Specnova was founded.

  2. January 2025: BodyTech Elite Creatine Beadlets launched.

  3. October 6, 2026: The acquisition was announced.

  4. October 28-30, 2026: Companies to exhibit at SupplySide Global 2026.

Market Landscape

This acquisition follows the industry pattern of ingredient manufacturers consolidating around proprietary delivery formats to secure competitive advantages. The companies will showcase their integrated capabilities at the 2026 SupplySide Global trade exhibition.

Operators in the supplement space should track how these delivery technologies translate into consumer-facing product differentiators. Monitor the upcoming product launches to see if these platforms shift market expectations for ingredient release performance.

The takeaway

This deal underscores the growing importance of proprietary delivery platforms as a key value proposition in the ingredient sector. Evaluate your own supply chain for opportunities to adopt advanced delivery technologies that may improve product performance and shelf presence.

What happens next

HealthTech Bio Actives will launch its Leanara product in the United States at the SupplySide Global trade show held from October 28 to 30, 2026.

Further reading

For more on industry shifts in the nutrition and wellness sector, see our coverage in Healthcare.

Source note: This article includes information reported by Nutritioninsight.

Live Poll

Do you believe corporate acquisitions generally lead to better product choices for your household?